High Tower Advisors, LLC Finch Therapeutics Group, Inc. Transaction History

High Tower Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.34 - $0.56 $102 - $168	-300 Reduced 2.12%	13,831 $5,000
Q3 2022 Nov 09, 2022	SELL	$1.75 - $51.3 $12,194 - $357,458	-6,968 Reduced 33.03%	14,131 $22,000
Q2 2022 Aug 10, 2022	BUY	$1.91 - $5.11 $5,730 - $15,330	3,000 Added 16.58%	21,099 $61,000
Q3 2021 Nov 12, 2021	BUY	$12.2 - $16.75 $39,174 - $53,784	3,211 Added 21.57%	18,099 $237,000
Q2 2021 Aug 06, 2021	BUY	$12.03 - $17.51 $44,150 - $64,261	3,670 Added 32.72%	14,888 $210,000
Q1 2021 May 10, 2021	BUY	$15.54 - $21.32 $174,327 - $239,167	11,218 New	11,218 $181,000

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $525M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.